ValuEngine upgraded shares of Hooper Holmes (OTCMKTS:HPHW) from a strong sell rating to a sell rating in a research report sent to investors on Friday morning.

Hooper Holmes (OTCMKTS HPHW) opened at $0.55 on Friday. Hooper Holmes has a 52 week low of $0.37 and a 52 week high of $1.10. The company has a quick ratio of 0.45, a current ratio of 0.51 and a debt-to-equity ratio of -1.57.

Hooper Holmes (OTCMKTS:HPHW) last announced its earnings results on Thursday, November 9th. The company reported ($0.21) earnings per share for the quarter. equities research analysts predict that Hooper Holmes will post -0.95 earnings per share for the current fiscal year.

In related news, Director Paul R. Daoust purchased 81,153 shares of the firm’s stock in a transaction that occurred on Monday, November 27th. The stock was acquired at an average price of $0.63 per share, for a total transaction of $51,126.39. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders have purchased 100,000 shares of company stock valued at $62,582 in the last ninety days. Company insiders own 52.44% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This piece was first published by Daily Political and is owned by of Daily Political. If you are accessing this piece on another website, it was stolen and reposted in violation of international copyright & trademark legislation. The correct version of this piece can be read at

About Hooper Holmes

Hooper Holmes, Inc is a provider of on-site screenings, laboratory testing, risk assessment and sample collection services to individuals as part of Health and Wellness programs offered through corporate and government employers, as well as to clinical research organizations. The Company, through its subsidiary Accountable Health Solutions, Inc, has various capabilities, including telephonic health coaching, wellness portals, data analytics and reporting services.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Hooper Holmes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hooper Holmes and related companies with's FREE daily email newsletter.